- Home
- SPTN vs KROS Comparison
SPTN vs KROS Comparison
Compare SPTN & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- KROS
- Stock Information
- Founded
- SPTN 1917
- KROS 2015
- Country
- SPTN United States
- KROS United States
- Employees
- SPTN N/A
- KROS N/A
- Industry
- SPTN Food Distributors
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- KROS Health Care
- Exchange
- SPTN Nasdaq
- KROS Nasdaq
- Market Cap
- SPTN 618.4M
- KROS 589.8M
- IPO Year
- SPTN N/A
- KROS 2020
- Fundamental
- Price
- SPTN $18.01
- KROS $10.86
- Analyst Decision
- SPTN Hold
- KROS Buy
- Analyst Count
- SPTN 1
- KROS 11
- Target Price
- SPTN $20.00
- KROS $45.33
- AVG Volume (30 Days)
- SPTN 333.6K
- KROS 2.0M
- Earning Date
- SPTN 02-13-2025
- KROS 02-26-2025
- Dividend Yield
- SPTN 4.83%
- KROS N/A
- EPS Growth
- SPTN 9.92
- KROS N/A
- EPS
- SPTN 1.33
- KROS N/A
- Revenue
- SPTN $9,532,883,000.00
- KROS $651,000.00
- Revenue This Year
- SPTN N/A
- KROS $303.39
- Revenue Next Year
- SPTN $2.15
- KROS N/A
- P/E Ratio
- SPTN $13.55
- KROS N/A
- Revenue Growth
- SPTN N/A
- KROS 8037.50
- 52 Week Low
- SPTN $17.30
- KROS $9.78
- 52 Week High
- SPTN $23.00
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- SPTN 42.39
- KROS 20.25
- Support Level
- SPTN $17.30
- KROS $9.78
- Resistance Level
- SPTN $18.31
- KROS $16.49
- Average True Range (ATR)
- SPTN 0.43
- KROS 0.92
- MACD
- SPTN 0.03
- KROS 0.97
- Stochastic Oscillator
- SPTN 51.82
- KROS 14.52
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.